密爾克衞(603713.SH):寧波慎則簽署1.45億元《建設工程施工合同》
格隆匯12月5日丨密爾克衞(603713.SH)公佈,公司全資子公司寧波慎則化工供應鏈管理有限公司(以下簡稱“寧波慎則”)以總價4952.47萬元競得位於梅山問津路西、梅山大道南地段的國有建設用地使用權,並簽訂《國有建設用地使用權出讓合同》,該宗土地為“倉儲用地”。
根據招投標結果,寧波慎則與浙江偉辰建設有限公司(以下簡稱“偉辰建設”)於2019年12月4日正式簽訂《建設工程施工合同》,合同約定,由偉辰建設承包“寧波慎則化工供應鏈管理有限公司項目”工程,合同金額為1.45億元。
本次合同的簽署將加快“寧波慎則化工供應鏈管理有限公司項目”即化學品倉庫建設進度,該項目旨在推進“昤元素”電商平台的優化升級及化工品線下貿易分銷平台的打造,擴展公司的經營規模、提升公司的盈利能力、強化公司的競爭優勢、有助於公司實現長期戰略目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.